07 May 2020 | Views
Dr Shravan Subramanyam, Managing Director - Roche Diagnostics India, Mumbai shares his views on the current COVID-19 situation
"India is adopting a testing strategy that has been at par with international standards. From bringing the globally used tests to the country in record time to establishing the disease control measures by creating COVID-19 diagnostic hubs and enabling different types of testing at various stages of disease spread, the Indian Government and the State Governments have been collaborating with various sections of the healthcare system to manage the situation. Laboratory-based immunodiagnostic testing will complement the existing reverse transcription polymerase chain reaction (RT-PCR) solutions to possibly ascertain COVID-19 related immunity amongst patients and all who want to ‘go back to work’ to bring the health and economic activity back to normalcy."
- Dr Shravan Subramanyam, Managing Director - Roche Diagnostics India, Mumbai